Piramal Enterprises hit with nearly $172 million tax bill for pharma deal
India's Piramal Enterprises said in an exchange filing on Friday that it had received a tax demand of Rs 1,502 crore (nearly $172 million) for the sale of its pharmaceutical business to Piramal Pharma in fiscal year 2021.
/connect-gujarat-english/media/media_files/2025/03/02/zZePHByh55lEytHkgpLe.jpeg)
/connect-gujarat-english/media/media_files/2025/03/01/RTckUWvPE6dUme9XDemg.jpeg)
/connect-gujarat-english/media/media_files/2025/02/28/iduYFRuaL3UhKR56VYjx.jpeg)
/connect-gujarat-english/media/media_files/2025/02/27/vyhwlQ29MPQa5vuqtMSs.jpeg)
/connect-gujarat-english/media/media_files/2025/02/26/ZCzHuSmJXlEMoaEDnOP4.jpeg)
/connect-gujarat-english/media/media_files/2025/02/25/m1PS14NEnUj6BWXtb2vK.jpeg)
/connect-gujarat-english/media/media_files/2025/02/24/O1Y3xsODu1hzR6QRtp8M.jpeg)
/connect-gujarat-english/media/media_files/2025/02/22/xxDh0yZZZWbekTfz4ACR.jpeg)
/connect-gujarat-english/media/media_files/2025/02/20/ddKgJm2yiWm1AdmOsdmJ.jpeg)
/connect-gujarat-english/media/media_files/2025/02/19/4c9iBJFlaAW2yT96YiMN.jpeg)